REPHライブシグナル | Getagraph.comで利益を最大化

Live Chart Being Loaded With Signals

Commentary (22 3月 2022 @ 13:00):

Stats
本日の出来高	137 536
平均出来高	128 488
時価総額	177.42M
EPS	$-0.0000600 ( 2023-03-30 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-8.04
ATR14	$0.0920 (4.40%)

Insider Trading

Date	Person	Action	Amount	type
2024-01-02	Lake Ryan David	Sell	1 419	Common Stock
2023-12-15	Lake Ryan David	Sell	5 690	Common Stock
2023-11-30	Lake Ryan David	Sell	1 197	Common Stock
2023-10-31	Lake Ryan David	Sell	1 198	Common Stock
2023-09-30	Lake Ryan David	Sell	1 198	Common Stock

INSIDER POWER
94.69
Last 95 transactions
Buy: 16 300 004 \| Sell: 826 395

ボリューム相関

長: -0.07 (neutral)

短: 0.64 (weak)

Signal:(67.783) Neutral

Recro Pharma Inc 相関

10 最も正の相関
CNDT	0.875
EGBN	0.874
ANNX	0.87
FEYE	0.863
CYXT	0.863
FNWB	0.861
DCOMP	0.858
FFWM	0.852
ATHA	0.846
BWBBP	0.843

10 最も負の相関
NRDS	-0.898
SGTX	-0.876
NVTS	-0.859
PESI	-0.851
MORF	-0.848
WVVI	-0.844
BTBD	-0.839
FTIV	-0.837
INOD	-0.836
AMRB	-0.835

知っていましたか？

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関（1つの変数が増加すると、もう一方は減少する）、1は完全な正の相関（1つの変数が増加すると、もう一方も増加する）、0は相関がないことを示します（変数間に関係がない）。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

Recro Pharma Inc 相関 - 通貨/商品

0.43
( neutral )

0.42
( neutral )

0.00
( neutral )

0.50
( neutral )

0.10
( neutral )

-0.50
( neutral )

Recro Pharma Inc 財務諸表

Annual	2023
収益:	$94.64M
総利益:	$18.14M (19.17 %)
EPS:	$-0.000100

FY	2023
収益:	$94.64M
総利益:	$18.14M (19.17 %)
EPS:	$-0.000100

FY	2022
収益:	$90.21M
総利益:	$23.14M (25.65 %)
EPS:	$-0.340

FY	2021
収益:	$75.36M
総利益:	$19.82M (26.30 %)
EPS:	$-0.221

Financial Reports:

No articles found.

Recro Pharma Inc

Recro Pharma, Inc., a contract development and manufacturing organization, engages in the development, manufacturing, and packaging for various therapeutic dosage forms primarily in the small molecule therapeutic development in the United States and internationally. It offers its products in the form of oral solid doses, sterile injectables, oral liquids, tablets, topicals, liquid/powder filled capsules, ophthalmic droppers, liposomes, and nano/microparticles, as well as in the areas of aseptic fill/finish, lyophilization, packaging, and logistics services. The company was formerly known as Recro Pharma I, Inc. and changed its name to Recro Pharma, Inc. in August 2008. Recro Pharma, Inc. was incorporated in 2007 and is based in Exton, Pennsylvania.